Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year post-insertion: a systematic review and meta-analysis.

Maldonado LY, Sergison JE, Gao X, Hubacher D.

Am J Obstet Gynecol. 2019 Oct 4. pii: S0002-9378(19)31210-4. doi: 10.1016/j.ajog.2019.09.044. [Epub ahead of print] Review.

PMID:
31589865
2.

Scientific abstracts: Featured research at the 2019 Society of Family Planning Annual Meeting.

Teal S, Haider S, Harris L, Hubacher D, Raine-Bennett T.

Contraception. 2019 Jul 23:303-304. doi: 10.1016/j.contraception.2019.07.007. [Epub ahead of print] No abstract available.

PMID:
31472941
3.

Levonorgestrel intrauterine system associated amenorrhea: a systematic review and metaanalysis.

Sergison JE, Maldonado LY, Gao X, Hubacher D.

Am J Obstet Gynecol. 2019 May;220(5):440-448.e8. doi: 10.1016/j.ajog.2018.12.008. Epub 2018 Dec 7. Review.

4.

Scientific abstracts featured research at the 2018 North American Forum on Family Planning.

Teal S, Borrero S, Hubacher D, Madden T, Raine-Bennett T.

Contraception. 2018 Oct;98(4):329-330. doi: 10.1016/j.contraception.2018.07.007. Epub 2018 Jul 19. No abstract available.

PMID:
30031790
5.

Opportunity, satisfaction, and regret: Trying long-acting reversible contraception in a unique scientific circumstance.

Burke HM, Packer CA, Spector HL, Hubacher D.

Women Health. 2019 Mar;59(3):266-280. doi: 10.1080/03630242.2018.1478363. Epub 2018 Aug 1.

PMID:
29920171
6.

Historical record-setting trends in IUD use in the United States.

Hubacher D, Kavanaugh M.

Contraception. 2018 Dec;98(6):467-470. doi: 10.1016/j.contraception.2018.05.016. Epub 2018 May 26. No abstract available.

PMID:
29842865
7.

Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.

Hubacher D, Spector H, Monteith C, Chen PL.

Contraception. 2018 Jun;97(6):524-532. doi: 10.1016/j.contraception.2018.02.001. Epub 2018 Feb 19.

8.

Long-acting reversible contraception acceptability and satisfaction is high among adolescents.

Hubacher D.

Evid Based Med. 2017 Dec;22(6):228-229. doi: 10.1136/ebmed-2017-110768. Epub 2017 Sep 18. No abstract available.

PMID:
28924056
9.

Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.

Ali M, Akin A, Bahamondes L, Brache V, Habib N, Landoulsi S, Hubacher D; WHO study group on subdermal contraceptive implants for women.

Hum Reprod. 2016 Nov;31(11):2491-2498. Epub 2016 Sep 26.

10.

Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.

Hubacher D, Spector H, Monteith C, Chen PL, Hart C.

Am J Obstet Gynecol. 2017 Feb;216(2):101-109. doi: 10.1016/j.ajog.2016.08.033. Epub 2016 Sep 20.

11.

Response to letter.

Hubacher D, Trussell J.

Contraception. 2016 Jun;93(6):566. doi: 10.1016/j.contraception.2016.01.016. No abstract available.

PMID:
27132988
12.

The Levonorgestrel Intrauterine System: Reasons to Expand Access to the Public Sector of Africa.

Hubacher D.

Glob Health Sci Pract. 2015 Oct 28;3(4):532-7. doi: 10.9745/GHSP-D-15-00178. No abstract available.

13.

A definition of modern contraceptive methods.

Hubacher D, Trussell J.

Contraception. 2015 Nov;92(5):420-1. doi: 10.1016/j.contraception.2015.08.008. Epub 2015 Aug 11. No abstract available.

PMID:
26276245
14.

Interventions for pain with intrauterine device insertion.

Lopez LM, Bernholc A, Zeng Y, Allen RH, Bartz D, O'Brien PA, Hubacher D.

Cochrane Database Syst Rev. 2015 Jul 29;(7):CD007373. doi: 10.1002/14651858.CD007373.pub3. Review.

PMID:
26222246
15.

Immediate postpartum insertion of intrauterine device for contraception.

Lopez LM, Bernholc A, Hubacher D, Stuart G, Van Vliet HA.

Cochrane Database Syst Rev. 2015 Jun 26;(6):CD003036. doi: 10.1002/14651858.CD003036.pub3. Review.

PMID:
26115018
16.

Intrauterine devices & infection: review of the literature.

Hubacher D.

Indian J Med Res. 2014 Nov;140 Suppl:S53-7. Review.

17.

The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya.

Hubacher D, Masaba R, Manduku CK, Chen M, Veena V.

Contraception. 2015 Apr;91(4):295-300. doi: 10.1016/j.contraception.2015.01.009. Epub 2015 Jan 16.

PMID:
25601351
18.

Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.

Hubacher D, Spector H, Monteith C, Chen PL, Hart C.

Contraception. 2015 Mar;91(3):185-92. doi: 10.1016/j.contraception.2014.11.006. Epub 2014 Nov 15.

19.

Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya.

Todd CS, Deese J, Wang M, Hubacher D, Steiner MJ, Otunga S, Van Damme L; FEM-PrEP Study Group.

Contraception. 2015 Mar;91(3):248-52. doi: 10.1016/j.contraception.2014.10.008. Epub 2014 Oct 22.

PMID:
25459097
20.

Introduction of the levonorgestrel intrauterine system in Kenya through mobile outreach: review of service statistics and provider perspectives.

Hubacher D, Akora V, Masaba R, Chen M, Veena V.

Glob Health Sci Pract. 2014 Jan 9;2(1):47-54. doi: 10.9745/GHSP-D-13-00134. eCollection 2014 Feb.

21.

Characteristics of Kenyan women in a prospective cohort study who continue using subdermal contraceptive implants at 12 months.

O'Neill E, Tang J, Garrett J, Hubacher D.

Contraception. 2014 Mar;89(3):204-8. doi: 10.1016/j.contraception.2013.11.016. Epub 2013 Nov 26.

PMID:
24360643
22.

Pitfalls of research linking the intrauterine device to pelvic inflammatory disease.

Hubacher D, Grimes DA, Gemzell-Danielsson K.

Obstet Gynecol. 2013 May;121(5):1091-8. doi: 10.1097/AOG.0b013e31828ac03a.

PMID:
23635748
23.

Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.

Hubacher D, Masaba R, Manduku CK, Veena V.

Contraception. 2013 Jul;88(1):97-102. doi: 10.1016/j.contraception.2013.03.001. Epub 2013 Mar 13.

PMID:
23566383
24.

Effect of concurrent use of anti-retroviral therapy and levonorgestrel sub-dermal implant for contraception on CD4 counts: a prospective cohort study in Kenya.

Hubacher D, Liku J, Kiarie J, Rakwar J, Muiruri P, Omwenga J, Chen PL.

J Int AIDS Soc. 2013 Mar 1;16:18448. doi: 10.7448/IAS.16.1.18448.

25.

Use of hormonal contraceptives and risk of HIV-1 transmission.

Hubacher D.

Lancet Infect Dis. 2012 Jul;12(7):508; author reply 510-1. doi: 10.1016/S1473-3099(12)70114-7. No abstract available.

PMID:
22742628
26.

Preventing unintended pregnancy among young women in Kenya: prospective cohort study to offer contraceptive implants.

Hubacher D, Olawo A, Manduku C, Kiarie J, Chen PL.

Contraception. 2012 Nov;86(5):511-7. doi: 10.1016/j.contraception.2012.04.013. Epub 2012 May 26.

PMID:
22633247
27.

Avoiding controversy in international provision of subdermal contraceptive implants.

Hubacher D, Dorflinger L.

Contraception. 2012 May;85(5):432-3. doi: 10.1016/j.contraception.2011.11.018. Epub 2012 Jan 20. No abstract available.

PMID:
22264665
28.

Factors associated with uptake of subdermal contraceptive implants in a young Kenyan population.

Hubacher D, Olawo A, Manduku C, Kiarie J.

Contraception. 2011 Oct;84(4):413-7. doi: 10.1016/j.contraception.2011.02.007. Epub 2011 Mar 23.

PMID:
21920198
29.

Characteristics of women in the United States who use long-acting reversible contraceptive methods.

Kavanaugh ML, Jerman J, Hubacher D, Kost K, Finer LB.

Obstet Gynecol. 2011 Jun;117(6):1349-57. doi: 10.1097/AOG.0b013e31821c47c9.

PMID:
21606745
30.

Dedicated providers of long-acting reversible contraception: new approach in Zambia.

Neukom J, Chilambwe J, Mkandawire J, Mbewe RK, Hubacher D.

Contraception. 2011 May;83(5):447-52. doi: 10.1016/j.contraception.2010.08.021. Epub 2010 Oct 8.

PMID:
21477688
31.

Renewed interest in intrauterine contraception in the United States: evidence and explanation.

Hubacher D, Finer LB, Espey E.

Contraception. 2011 Apr;83(4):291-4. doi: 10.1016/j.contraception.2010.09.004. Epub 2010 Oct 18. No abstract available.

PMID:
21397085
32.

Measuring the usefulness of family planning job aids following distribution at training workshops.

Tumlinson K, Hubacher D, Wesson J, Lasway C.

J Biosoc Sci. 2010 Sep;42(5):695-8.

PMID:
20695036
33.

Assessment of a disposable trocar for insertion of contraceptive implants.

Steiner MJ, Boler T, Obhai G, Hubacher D.

Contraception. 2010 Feb;81(2):140-2. doi: 10.1016/j.contraception.2009.08.006. Epub 2009 Sep 30.

PMID:
20103452
34.

Cancer risk after sterilization with transcervical quinacrine: updated findings from a Chilean cohort.

Sokal DC, Trujillo V, Guzmán SC, Guzman-Serani R, Wheeless A, Hubacher D.

Contraception. 2010 Jan;81(1):75-8. doi: 10.1016/j.contraception.2009.07.006.

PMID:
20004277
35.

Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons.

Hubacher D, Lopez L, Steiner MJ, Dorflinger L.

Contraception. 2009 Aug;80(2):113-8. doi: 10.1016/j.contraception.2009.02.008. Epub 2009 Apr 23. Review.

PMID:
19631785
36.

Interventions for pain with intrauterine device insertion.

Allen RH, Bartz D, Grimes DA, Hubacher D, O'Brien P.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007373. doi: 10.1002/14651858.CD007373.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;7:CD007373.

PMID:
19588429
37.

Side effects from the copper IUD: do they decrease over time?

Hubacher D, Chen PL, Park S.

Contraception. 2009 May;79(5):356-62. doi: 10.1016/j.contraception.2008.11.012.

38.

Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it.

Hubacher D, Mavranezouli I, McGinn E.

Contraception. 2008 Jul;78(1):73-8. doi: 10.1016/j.contraception.2008.03.002. Epub 2008 May 14.

PMID:
18555821
39.

Safety of quinacrine contraceptive pellets: results from 10-year follow-up in Vietnam.

Sokal DC, Hieu do T, Loan ND, Hubacher D, Nanda K, Weiner DH, Vach TH.

Contraception. 2008 Jul;78(1):66-72. doi: 10.1016/j.contraception.2008.02.011. Epub 2008 Apr 16.

PMID:
18555820
40.

Contraceptive effectiveness of two insertions of quinacrine: results from 10-year follow-up in Vietnam.

Sokal DC, Hieu do T, Loan ND, Hubacher D, Nanda K, Weiner DH, Vach TH.

Contraception. 2008 Jul;78(1):61-5. doi: 10.1016/j.contraception.2008.02.010. Epub 2008 Apr 28.

PMID:
18555819
41.

Hormonal contraception and the risks of STI acquisition: results of a feasibility study to plan a future randomized trial.

Hubacher D, Raymond ER, Beksinska M, Delany-Moretlwe S, Smit J, Hylton-Kong T, Moench TR.

Contraception. 2008 May;77(5):366-70. doi: 10.1016/j.contraception.2008.01.006. Epub 2008 Mar 18.

PMID:
18402854
42.

Copper intrauterine device use by nulliparous women: review of side effects.

Hubacher D.

Contraception. 2007 Jun;75(6 Suppl):S8-11. Epub 2007 Feb 20. Review.

PMID:
17531622
43.

Contraceptive implants in Kenya: current status and future prospects.

Hubacher D, Kimani J, Steiner MJ, Solomon M, Ndugga MB.

Contraception. 2007 Jun;75(6):468-73. Epub 2007 Apr 26.

PMID:
17519154
44.

Response to Morrison et al., "Hormonal contraception and the risk of HIV acquisition".

Raymond EG, Moench T, Feldblum P, Hubacher D.

AIDS. 2007 Apr 23;21(7):887. No abstract available.

PMID:
17415053
45.

Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen.

Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H.

Am J Obstet Gynecol. 2006 Nov;195(5):1272-7.

PMID:
17074548
46.

Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use.

Grimes DA, Hubacher D, Lopez LM, Schulz KF.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006034. Review.

PMID:
17054271
47.

The impact of clinician education on IUD uptake, knowledge and attitudes: results of a randomized trial.

Hubacher D, Vilchez R, Gmach R, Jarquin C, Medrano J, Gadea A, Grey T, Pierre-Louis B.

Contraception. 2006 Jun;73(6):628-33. Epub 2006 Mar 29.

PMID:
16730497
48.

Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen.

Hubacher D, Reyes V, Lillo S, Pierre-Louis B, Zepeda A, Chen PL, Croxatto H.

Hum Reprod. 2006 Jun;21(6):1467-72. Epub 2006 Feb 16.

PMID:
16484309
49.

The Good Clinical Practice guideline: a bronze standard for clinical research.

Grimes DA, Hubacher D, Nanda K, Schulz KF, Moher D, Altman DG.

Lancet. 2005 Jul 9-15;366(9480):172-4. No abstract available.

PMID:
16005342
50.

Outcomes monitoring of health, behavior, and quality of life after nutrition intervention in adults with type 2 diabetes.

Lemon CC, Lacey K, Lohse B, Hubacher DO, Klawitter B, Palta M.

J Am Diet Assoc. 2004 Dec;104(12):1805-15.

PMID:
15565074

Supplemental Content

Loading ...
Support Center